A
Arctoris
Arctoris is the world's first fully-automated drug discovery data engine, generating valuable insights for biotech and pharma partners
About Arctoris
Arctoris operates in the drug discovery sector, leveraging advanced robotics and wet lab automation to generate high-quality, reproducible datasets. The company serves biotech firms, pharmaceutical corporations, and AI-driven drug discovery companies globally. Arctoris developed Ulysses, a unique platform that enhances decision-making in drug discovery by providing data of unprecedented quality, depth, and context. The business model revolves around partnering with clients to accelerate the drug development process, from initial idea to clinical trials, thereby enabling faster delivery of new drugs to patients. Revenue is generated through service contracts and partnerships with companies in the life sciences sector. The company’s team comprises experienced scientists, engineers, and life sciences executives who provide consulting and advisory services to optimize assay cascades and the drug discovery pathway.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Oxford, United Kingdom
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Tanarra- TVTD Veen
- RPRT Partners
Future Planet Capital
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arctoris on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arctoris on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
